Chen, M.; Kane, T.; Chen, I.; Supabphol, S.; Zhang, X.; Wolfarth, A.A.; Choi, D.; Li, L.; Goedegebuure, S.P.; Gillanders, W.E.
Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines. Cancers 2025, 17, 3177.
https://doi.org/10.3390/cancers17193177
AMA Style
Chen M, Kane T, Chen I, Supabphol S, Zhang X, Wolfarth AA, Choi D, Li L, Goedegebuure SP, Gillanders WE.
Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines. Cancers. 2025; 17(19):3177.
https://doi.org/10.3390/cancers17193177
Chicago/Turabian Style
Chen, Michael, Thomas Kane, Ina Chen, Suangson Supabphol, Xiuli Zhang, Alexandra A. Wolfarth, Donghoon Choi, Lijin Li, S. Peter Goedegebuure, and William E. Gillanders.
2025. "Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines" Cancers 17, no. 19: 3177.
https://doi.org/10.3390/cancers17193177
APA Style
Chen, M., Kane, T., Chen, I., Supabphol, S., Zhang, X., Wolfarth, A. A., Choi, D., Li, L., Goedegebuure, S. P., & Gillanders, W. E.
(2025). Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines. Cancers, 17(19), 3177.
https://doi.org/10.3390/cancers17193177
